Study guide
3.2 Tear Film Dynamics, Dry Eye & Severe Ocular Surface Disease
ABO-NCLE Advanced Contact Lens Certification Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Corneal Topography, Tomography & Anterior Segment Imaging
1.1 Placido-Based Corneal Topography: Axial, Tangential & Elevation Maps 1.2 Corneal Tomography & Scheimpflug Imaging: Anterior/Posterior Elevation & Pachymetry 1.3 Topographic Indices, Asphericity & Cone Localization
2 Chapter 2: Complex Corneal Conditions & Surgical Alterations
2.1 Keratoconus, Pellucid Marginal Degeneration & Keratoglobus 2.2 Post-Keratoplasty (PKP/DALK) & Corneal Cross-Linking (CXL) 2.3 Post-Refractive Ectasia & Post-Refractive Surgery Corneas
3 Chapter 3: Prefit Ocular Surface Evaluation & Candidacy Assessment
3.1 Slit-Lamp Biomicroscopy & Ocular Surface Vital Staining 3.2 Tear Film Dynamics, Dry Eye & Severe Ocular Surface Disease 3.3 Patient History, Visual Needs Analysis & Specialty Lens Selection Strategy
4 Chapter 4: Scleral Lens Design Fundamentals & Sagittal Depth
4.1 Scleral Anatomy, Terminology & Sagittal Depth Principles 4.2 Central Corneal & Limbal Vault Clearance Optimization 4.3 Landing Zone Toricity, Quadrant-Specific Haptics & Edge Profiles
5 Chapter 5: Corneal RGP & Specialty Toric Designs for Irregular Corneas
5.1 Corneal RGP Fitting Philosophies: Apical Clearance vs Bearing vs Three-Point Touch 5.2 Bitoric & High-Toric RGP Calculations: SPE vs CPE & Induced Cylinder 5.3 Lens Materials, Hyper-Dk Polymers & Surface Coatings
6 Chapter 6: Hybrid & Piggyback Contact Lens Systems
6.1 Hybrid Lens Architecture: Rigid Center & Soft Hydrophilic Skirt Fitting 6.2 Hybrid Parameter Selection, Movement & Tear Exchange Optimization 6.3 Piggyback Systems: Carrier Selection, Power Calculations & Hypoxia Prevention
7 Chapter 7: Orthokeratology & Custom Prosthetic Lenses
7.1 Orthokeratology Reverse-Geometry Principles, Jessen Formula & Topographic Patterns 7.2 Prosthetic, Occlusive & Custom Soft Specialty Lenses for Irregular Corneas
8 Chapter 8: Specialty Lens Delivery, Application & Removal Techniques
8.1 Scleral Lens Application Protocols, Plungers & Bubble Prevention 8.2 Scleral, Hybrid & RGP Removal Techniques & Emergency Extraction 8.3 Patient Handling Training, Hygiene & Lens Inspection at Dispense
9 Chapter 9: Filling Solutions, Chemical Disinfection & Wearing Schedules
9.1 Preservative-Free Scleral Reservoir Filling Solutions & Fluid Dynamics 9.2 Disinfection Regimens, Conditioning Systems, Hydra-PEG Care & Adaptation Schedules
10 Chapter 10: Slit-Lamp Fit Evaluation & Optical Troubleshooting
10.1 Settling Time Dynamics & Slit-Lamp Evaluation of Vault Clearance 10.2 Midday Fogging, Tear Reservoir Debris & Lens Surface Wettability 10.3 Over-Refraction, Lenticular Astigmatism & Lens Flexure vs Warpage
11 Chapter 11: In-Office & Laboratory Specialty Lens Modifications
11.1 In-Office Corneal RGP Modifications: Edge Blending, Polishing & Power Changes 11.2 Scleral Parameter Adjustments: Sagittal Depth, Landing Zones & Micro-Vaults 11.3 Ortho-K & Hybrid Fit Problem Solving and Parameter Modifications
12 Chapter 12: Acute Complications, Corneal Pathology & Emergency Triage
12.1 Corneal Hypoxia, Neovascularization & Graft Rejection Recognition 12.2 Mechanical Staining Patterns, Dimple Veiling, Impingement & Conjunctival Prolapse 12.3 Infectious Keratitis, Infiltrative Events & Acute Triage Protocols
13 Chapter 13: Clinical Infection Control, Regulatory Standards & Practice Management
13.1 Diagnostic Fitting Set Decontamination, OSHA & Clinical Infection Control 13.2 FCLCA, Contact Lens Rule, FDA Regulatory Standards & SOAP Documentation
3.2 Tear Film Dynamics, Dry Eye & Severe Ocular Surface Disease
Key Takeaways Explain This Topic AI
The contemporary tear film architecture is defined by a two-layer model: an anterior non-polar and polar lipid layer (40–100 nm) and an underlying muco-aqueous gel layer (~3–4 µm) containing mucins, electrolytes, and immunoglobulins.
A fluorescein Tear Break-Up Time (TBUT) < 10 seconds indicates tear film instability, with < 5 seconds signifying severe evaporative dry eye; Non-Invasive TBUT (NITBUT) avoids the destabilizing hyperosmolar effect of fluorescein instillation.
Schirmer I without anesthesia samples basal plus reflex tearing; testing after topical anesthesia reduces reflex stimulation but does not perfectly isolate basal secretion, so technique and the rest of the dry-eye evaluation matter.
Tear osmolarity above 308 mOsm/L in either eye or an inter-eye difference above 8 mOsm/L is one commonly used abnormal finding, but variability means it supports rather than independently confirms dry-eye disease.
Therapeutic scleral lenses restore ocular surface integrity in conditions like Sjögren's, oGVHD, SJS/TEN, and neurotrophic keratitis by vaulting the cornea with a continuous fluid reservoir and shielding the epithelium from eyelid shearing forces.
Last updated: September 2026
3.2 Tear Film Dynamics, Dry Eye & Severe Ocular Surface Disease
The prefit evaluation of tear film dynamics is pivotal in specialty contact lens practice. The tear film serves not only as the primary refracting optical interface of the human eye (accounting for approximately +43.00 D of refractive power at the air-tear interface), but also as a biological lubricant, nutrient supply, and immunological barrier. A compromised tear film can transform an otherwise well-fitted specialty lens into an unwearable, sight-threatening hazard.
The Contemporary Tear Film Model
Historic teaching posited a strict three-layer model of the precorneal tear film (lipid, aqueous, and mucin layers; Wolff, 1946). Modern biochemical and biophysical research (TFOS DEWS II) has supplanted this with a two-layer model consisting of an anterior lipid layer overlying a continuous muco-aqueous gel phase:
Preocular Lipid Layer ( 40 – 100 nm 40\text{--}100\text{ nm} 40 – 100 nm ):
Origin: Secreted primarily by the holocrine meibomian glands situated within the tarsal plates of the upper and lower eyelids.
Architecture: Subdivided into an outer non-polar lipid sublayer (cholesteryl esters, wax esters, triglycerides) that directly interfaces with air to retard tear evaporation and lower surface tension, and an inner polar lipid sublayer (phospholipids, sphingolipids, ω \omega ω -hydroxy fatty acids) that functions as an amphiphilic surfactant bridging the non-polar lipids with the aqueous phase.
Muco-Aqueous Gel Layer ( ∼ 3 – 4 μ m \sim 3\text{--}4\ \mu\text{m} ∼ 3 – 4 μ m ):
Origin: Secreted jointly by the main and accessory lacrimal glands (Krause and Wolfring) and conjunctival goblet cells .
Architecture: A hydrated gel exhibiting a continuous concentration gradient. Near the epithelial microplicae, large membrane-associated transmembrane mucins ( MUC1, MUC4, MUC16 ) form the glycocalyx , transforming the intrinsically hydrophobic epithelial cell membrane into an ultra-hydrophilic surface.
Dispersed throughout the aqueous liquid are soluble gel-forming mucins ( MUC5AC , secreted by goblet cells) and soluble monomeric mucins ( MUC7 ), co-existing with crucial electrolytes, antibacterial enzymes (lysozyme, lactoferrin), immunoglobulins (secretory IgA), and trophic peptide growth factors (epidermal growth factor, nerve growth factor).
Clinical Battery for Tear Film Dynamics
A rigorous diagnostic battery differentiates aqueous-deficient dry eye (ADDE) from evaporative dry eye (EDE), determining whether a patient requires medical pre-treatment or therapeutic lens intervention. +------------------------------------------------------------------------------------------+
- | TEAR FILM DIAGNOSTIC BATTERY |
- +-------------------------+--------------------------------+-------------------------------+
- | Test Parameter | Normative Standard | Pathological Diagnostic Cutoff|
- +-------------------------+--------------------------------+-------------------------------+
- | Fluorescein TBUT (FBUT) | > 10 seconds | < 5 seconds (Severe EDE) |
- | Non-Invasive TBUT | First break > 10 s; avg > 14 s | < 10 seconds |
- | Schirmer I (no anesth.) | > 15 mm in 5 minutes | < 5 mm in 5 min (Severe ADDE) |
- | Schirmer I (with anesth)| > 10 mm in 5 minutes | < 5 mm in 5 minutes |
- | Schirmer II (nasal st.) | > 15 mm in 5 minutes | < 15 mm (Reflex arc failure) |
- | Tear Meniscus Ht. (TMH) | ≥ 0.20 mm | < 0.18 mm (Volume depletion) |
- | Tear Osmolarity | 290–300 mOsm/L | > 308 mOsm/L (or Δ > 8 mOsm/L)|
- +-------------------------+--------------------------------+-------------------------------+
- 1. Tear Break-Up Time (TBUT & NITBUT)
Fluorescein Tear Break-Up Time (TBUT / FBUT):
Method: Instill 5 μ L 5\ \mu\text{L} 5 μ L of preservative-free sodium fluorescein or a minimally moistened diagnostic strip into the inferior conjunctival sac. The patient blinks three times and then holds the eyes open under broad cobalt blue slit illumination with a yellow barrier filter. The time elapsed between the last complete blink and the appearance of the first black, non-fluorescent dry spot or fissure in the green tear film is timed in seconds.
Interpretation: Normal > 10 s >10\text{ s} > 10 s ; Borderline 5 – 10 s 5\text{--}10\text{ s} 5 – 10 s ; Abnormal < 5 s <5\text{ s} < 5 s (signifies severe tear film instability, typically driven by meibomian gland dysfunction or severe goblet cell mucin depletion).
Non-Invasive Tear Break-Up Time (NITBUT):
Evaluated using automated Placido ring projection reflection or videokeratoscopy. It measures the breakup of the specular mire reflection without instilling liquid dyes.
Clinical Advantage: Instilling liquid fluorescein alters tear film volume, lowers surface tension, and induces hyperosmolar reflex tearing. NITBUT eliminates these diagnostic artifacts.
2. The Schirmer Diagnostic Battery
Schirmer I Test (Without Anesthesia):
Measures total tear production—combining basal tear secretion and trigeminal reflex tearing .
A standardized sterile Whatman #41 filter paper strip ( 5 × 35 mm 5\times 35\text{ mm} 5 × 35 mm ) is folded 5 mm 5\text{ mm} 5 mm at the notch and placed over the lower eyelid margin at the junction of the middle and lateral thirds, avoiding corneal contact. The patient rests with eyes gently closed in a dimly lit room for 5 minutes.
Interpretation: Normal > 15 mm >15\text{ mm} > 15 mm ; Borderline 6 – 14 mm 6\text{--}14\text{ mm} 6 – 14 mm ; Severe aqueous deficiency < 5 mm <5\text{ mm} < 5 mm .
Schirmer I Test (With Topical Anesthesia):
One drop of 0.5 % 0.5\% 0.5% proparacaine is instilled, and excess anesthetic is carefully blotted from the inferior fornix prior to strip insertion.
Eliminates sensory reflex afferents from the ocular surface to isolate resting basal secretion .
Interpretation: Wetting < 5 mm <5\text{ mm} < 5 mm in 5 minutes confirms intrinsic basal lacrimal hyposecretion.
Schirmer II Test (Reflex Secretion):
Performed with topical anesthesia. A cotton-tipped applicator is used to mechanically irritate the nasal mucosa at the middle turbinate, stimulating the ethmoidal branch of Cranial Nerve V.
Evaluates the capacity of the efferent secretomotor fibers (parasympathetic branch of Cranial Nerve VII) to stimulate the lacrimal gland. Wetting < 15 mm <15\text{ mm} < 15 mm indicates failure of the secretomotor reflex or severe glandular parenchymal atrophy.
3. Tear Meniscus Height (TMH) & Tear Osmolarity
Tear Meniscus Height (TMH): Evaluated at the lower eyelid margin directly inferior to the pupil center using a slit-lamp graticule or anterior segment OCT. Normal TMH is ≥ 0.20 mm \ge 0.20\text{ mm} ≥ 0.20 mm . A TMH < 0.18 mm <0.18\text{ mm} < 0.18 mm signals aqueous volume reduction, and < 0.10 mm <0.10\text{ mm} < 0.10 mm indicates profound aqueous deficiency.
Tear Osmolarity: Measured via nanoliter electrical impedance sampling from the inferior lateral tear lake. Normal values range from 290 to 300 mOsm/L 290\text{ to }300\text{ mOsm/L} 290 to 300 mOsm/L . An absolute reading > 308 mOsm/L >308\text{ mOsm/L} > 308 mOsm/L in either eye, or an inter-eye difference > 8 mOsm/L >8\text{ mOsm/L} > 8 mOsm/L , supports tear-film homeostatic instability when interpreted with symptoms and other signs.
Severe Ocular Surface Diseases (OSD) in Specialty Practice
When medical therapies (preservative-free lubricants, topical cyclosporine/lifitegrast, punctal occlusion, autologous serum tears) fail to halt ocular surface breakdown, specialty lenses—most notably therapeutic scleral lenses —serve as a medical device to salvage vision and preserve ocular anatomy.
1. Sjögren's Syndrome
Etiology: Systemic autoimmune exocrinopathy characterized by lymphocytic infiltration and progressive destruction of the lacrimal and salivary glands.
Ocular Manifestations: Profound aqueous tear deficiency, severe filamentary keratitis, recurrent epithelial erosions, and increased risk of sterile corneal ulceration and perforation.
2. Ocular Graft-versus-Host Disease (oGVHD)
Etiology: A frequent, severe complication occurring in 40 % – 60 % 40\%\text{--}60\% 40% – 60% of patients following allogeneic hematopoietic stem cell transplantation (HSCT). Donor-derived T lymphocytes mount an immunological attack against host antigens.
Ocular Manifestations: Rapid-onset cicatricial conjunctivitis, dense lacrimal gland periductal fibrosis, severe meibomian gland ductal obliteration, symblepharon, pseudomembrane formation, and persistent epithelial defects (PEDs).
3. Stevens-Johnson Syndrome (SJS) & Toxic Epidermal Necrolysis (TEN)
Etiology: Acute, life-threatening cell-mediated hypersensitivity reaction usually triggered by medications (e.g., sulfonamides, anticonvulsants, NSAIDs, allopurinol). Causes widespread keratinocyte apoptosis and sloughing of mucosal membranes.
Ocular Sequelae: Destruction of conjunctival goblet cells, cicatricial entropion, trichiasis, keratinization of the eyelid margins and palpebral conjunctiva, symblepharon, and total limbal stem cell deficiency (LSCD). Blinking drives keratinized lids across the bare cornea like sandpaper.
4. Neurotrophic Keratitis (Cranial Nerve V Deficit)
Etiology: Impairment of trigeminal corneal sensory innervation (Cranial Nerve V, ophthalmic division V 1 V_1 V 1 ). Causes include herpes simplex keratitis, herpes zoster ophthalmicus, acoustic neuroma resection, neurosurgical trauma, or longstanding diabetes mellitus.
Pathophysiology: Corneal sensation provides vital trophic support; loss of sensory feedback deprives the cornea of substance P and nerve growth factor (NGF), leading to reduced epithelial mitosis, delayed wound healing, and decreased blink frequency.
Mackie Staging:
Stage 1: Epithelial irregularity, punctate keratopathy, and stromal clouding.
Stage 2: Persistent Epithelial Defect (PED), typically oval with thickened, smooth, rolled epithelial edges.
Stage 3: Corneal stromal melting, necrosis, and perforation.
5. Exposure Keratopathy (Cranial Nerve VII Palsy)
Etiology: Paresis or paralysis of the orbicularis oculi muscle driven by Facial Nerve (CN VII) deficits (e.g., Bell's palsy, acoustic neuroma resection, trauma) or anatomical lagophthalmos from thyroid eye disease (proptosis) or cicatricial lid retraction.
Ocular Manifestations: Inability to achieve complete eyelid closure leads to chronic nocturnal evaporative desiccation, primarily concentrated across the inferior third of the cornea, causing deep ulceration and perforation.
Therapeutic Mechanisms of Scleral Lenses in OSD
Therapeutic scleral lenses act as a prosthetic ocular surface environment through three core biophysical mechanisms: [Therapeutic Scleral Lens Functions in Severe OSD]
- ├── 1. Continuous Liquid Reservoir (150–350 µm unpreserved fluid)
- │ └── Bathes cornea 14–16 hrs/day; supports continuous epithelial hydration
- ├── 2. Mechanical Shielding
- │ └── Vaults cornea completely; insulates from lid shear, keratin, & trichiasis
- └── 3. Epithelial Regeneration & Pain Relief
- └── Accelerates PED healing; neutralizes irregular astigmatism
Continuous Corneal Liquid Reservoir: Scleral lenses vault completely over the cornea and limbus, resting entirely on the bulbar conjunctiva/sclera. The space between the posterior lens surface and the anterior cornea is filled with non-preserved physiological saline, creating a continuous, sealed liquid reservoir of 150 – 350 μ m 150\text{--}350\ \mu\text{m} 150 – 350 μ m . This reservoir keeps the corneal epithelium perpetually submerged in fluid, preventing desiccation regardless of blink rate, tear volume, or environmental humidity.
Mechanical Shielding: The rigid lens barrier physically insulates the fragile, regenerating corneal epithelium from the abrasive shearing forces of blinking eyelids, keratinized palpebral margins, and misdirected eyelashes (trichiasis).
Promotion of Epithelial Regeneration & Visual Rehabilitation: By maintaining hydration and eliminating friction, scleral lenses promote rapid closure of chronic persistent epithelial defects (PEDs) that have resisted conventional medical intervention. Concurrently, the fluid reservoir neutralizes irregular corneal astigmatism, restoring clear functional vision and providing dramatic relief from debilitating photophobia and ocular pain.